Joint health is no longer just about reducing discomfort—it’s about protecting cartilage at its source.
Recent research shows that Collavant® n2 significantly reduces CTX-II, a key biomarker of collagen breakdown, in healthy, active individuals following exercise. At just 40 mg/day, this provides objective evidence that the ingredient helps support cartilage integrity—not just symptoms.
Why It Matters
A reduction in CTX-II confirms:
-
Decreased cartilage degradation
-
Support for long-term joint health
-
Protection against daily wear and tear from activity
Proven Mechanism
Collavant® n2 works through an immune-mediated mechanism (oral tolerance), helping modulate the body’s response to its own collagen. The CTX-II results validate this mechanism with measurable biological impact.
Beyond Traditional Joint Health
Unlike many ingredients studied only in osteoarthritis, Collavant® n2 has demonstrated effectiveness in healthy, active individuals, making it highly relevant for:
-
Active nutrition
-
Healthy aging
-
Preventative joint care
A New Standard in Joint Health
With clear evidence of reducing cartilage breakdown at the molecular level, Collavant® n2 sets a new benchmark—moving beyond symptom relief to true structural support.
